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Leuven, BelgiumAbstract. Postoperative nausea and vomiting (PONV) is one of the most unpleasant
experiences after surgery. It reduces patient satisfaction and also increases hospital
costs due to longer hospitalizations. The aim of this prospective study was to
determine whether orthognathic surgery is associated with more PONV than less
invasive maxillofacial surgery. Three hundred and eight patients aged 8–87 years
who underwent maxillofacial surgery were included. The PONV score, based on the
Apfel score, was calculated preoperatively. PONV occurred in 142 (46.1%) patients
during the first three postoperative days; these patients were further categorized as
having postoperative nausea (PON) and/or postoperative vomiting (POV). PON
was most frequent after orthognathic surgery to the mandible (75%), and POV was
most frequent after maxillary surgery, including bimaxillary surgery, Le Fort I
osteotomy, and surgically assisted rapid palatal expansion (SARPE) (43.1%). There
was a small significant relationship between the preoperative PONV score and the
incidence of PONV: patients experienced more PONV when the PONV score
calculated preoperatively was higher. The incidence of PONV after orthognathic
surgery was very high compared with the incidence after dental extractions and
other minor surgeries. Further investigation is required to establish a strategy to
reduce PONV after orthognathic surgery.Key words: PONV; nausea; vomiting; compli-
cations; orthognathic surgery; anaesthesia;
prospective study; anti-emetic.
Accepted for publicationPostoperative nausea and vomiting
(PONV) is a common and frequent com-
plication after general anaesthesia1.
PONV leads to longer hospitalizations,thereby increasing healthcare costs, and
affected patients often have negative feel-
ings related to the surgery and anaesthe-
sia2. PONV is defined as nausea, retching,or vomiting during the first 2 days after
surgery3. The reported incidence varies
between 20% and 30%, but it can be as
high as 80% in high-risk patients3–5. Fur-g after oral and maxillofacial surgery: a
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Table 1. Distribution of the interventions to specific surgical groups.
Intervention Group Number
Arthroscopy TMJ surgery 11
BIMAX BIMAX/SARPE/Le Fort I 35
Biopsy Other minor surgery 1
Osteotomy, block Other minor surgery 1
Orthodontic bone anchors Other minor surgery 5
Bone augmentation Other minor surgery 19
BSSO BSSO 32
Cryotherapy Other minor surgery 1
Cystectomy Other minor surgery 2
Eminectomy TMJ surgery 1
Tooth extraction Dental extraction 39
Frenectomy Other minor surgery 2
Dental implants Other minor surgery 3
Le Fort I osteotomy BIMAX/SARPE/Le Fort I 6
Orbital floor fracture repair Other minor surgery 1
Oral tumour resection Other minor surgery 1
SARPE BIMAX/SARPE/Le Fort I 31
Sialoendoscopy Other minor surgery 1
Tooth transplantation Other minor surgery 11
Soft tissue surgery Other minor surgery 1
Vestibuloplasty Other minor surgery 1
Removal of osteosynthesis material Other minor surgery 29
Wisdom tooth removal Dental extraction 74
BIMAX, bimaxillary surgery; BSSO, bilateral sagittal split osteotomy; SARPE, surgically
assisted rapid palatal expansion; TMJ, temporomandibular joint.thermore, patients who undergo maxillo-
facial surgery are more predisposed to
PONV, especially after orthognathic sur-
gery to the maxilla6. This can be explained
by swallowed blood, an altered diet, and
hypotension in the perioperative period1.
Unfortunately, there are only a small
number of major studies demonstrating a
higher incidence of PONV after oral and
maxillofacial surgery. Perrott et al. found
PONV to be the most common of the
postoperative complications following
oral and maxillofacial surgery6. A high
incidence of PONV in orthognathic sur-
gery to the mandible and/or maxilla was
found by Silva et al.7. No other studies
have reported the incidence of PONV after
specific interventions in oral and maxillo-
facial surgery.
The purpose of this study was to identi-
fy the specific interventions in the field of
oral and maxillofacial surgery that are
more related to PONV. Risk factors for
PONV can be categorized into those as-
sociated with the preoperative period, the
perioperative period, and the postopera-
tive period, as outlined below.
Preoperative risk of PONV
The identification of patients at risk of
PONV remains a challenge8. Apfel et al.
developed a simplified risk score to predict
PONV9–11. The Apfel score assesses the
following: (1) female sex (this is a major
risk factor and triples the risk of PONV);
(2) history of motion sickness or PONV
(this indicates general susceptibility to
PONV); (3) smoking status (being a
non-smoker roughly doubles the risk of
PONV, although the underlying patho-
physiology remains unknown); (4) post-
operative opioid use (PONV shows a
dose-dependent association with opioid
use)8–13.
A screening score based on the Apfel
score was used in a previous study to
calculate the risk of PONV preoperatively
using different variables: each patient un-
dergoing surgery was asked about their
age (<50 years = 1, 50 years = 0), sex
(female = 1, male = 0), history of motion
sickness and/or PONV (yes = 1, no = 0),
and their smoking status (non-smoker = 1,
smoker = 0). The PONV score was then
calculated based on these patient-specific
variables, along with the predicted dura-
tion of the operation (<60 min = 0,
60 min = 1), predicted use of periopera-
tive and postoperative opioids (yes = 1,
no = 0), and the type of surgery (ophthal-
mological, orthopaedic, laparoscopic, oto-
laryngological, and other). These patients
undergoing general anaesthesia werePlease cite this article in press as: Dobbele
prospective study, Int J Oral Maxillofac Sufound to have scores ranging from 0.1
to 0.811.
Perioperative risk of PONV
General anaesthesia is associated with an
11-fold increased risk of PONV, which is
frequently caused by the emetic properties
of volatile anaesthetics and the opioids
administered13–15. In addition, the type
of surgery is an independent risk factor
for PONV1,4,16. If the risk of PONV is high
and general anaesthesia is required, the
use of intravenous propofol can reduce the
incidence of PONV17,18. Adequate peri-
operative intravenous fluid administration
also reduces PONV. This may be related to
a reduction in the release of serotonin,
which decreases in response to the reduc-
tion in systolic blood pressure that is asso-
ciated with intestinal hypoperfusion19–21.
Postoperative risk of PONV
Opioids are commonly used postopera-
tively after general anaesthesia4. Some
researchers have suggested that pain is a
primary factor that induces nausea in the
recovery unit22. Furthermore, PONV is
frequently associated with pain postoper-
atively23. At the University Hospitals Leu-
ven, the synthetic opioid piritramide is the
opioid most often used for postoperative
pain therapy.ir M, et al. Postoperative nausea and vomitin
rg (2018), https://doi.org/10.1016/j.ijom.2017Materials and methods
This prospective study included 308
patients aged 8 to 87 years who were
due to undergo general anaesthesia for
maxillofacial surgery. All surgical proce-
dures were performed at the University
Hospitals Leuven. Patients undergoing
oral and maxillofacial surgery at the hos-
pitals who agreed to participate and signed
the informed consent form were included.
If the patient was younger than 18 years of
age, a parental signature was obtained.
Patients under the age of 8 years and
patients who were unable to communicate
were excluded. Patients who underwent
major oncological surgery were also ex-
cluded from the protocol, due to their
postoperative stay in the intensive care
unit. The study was approved by the Ethics
Committee of the University Hospitals
Leuven. The maxillofacial surgeries were
categorized based on bleeding risk, as
follows24–27: maxillary osteotomy surgery
(bimaxillary surgery (BIMAX)/surgically
assisted rapid palatal expansion (SARPE)/
Le Fort I; n = 72), bilateral sagittal split
osteotomy (BSSO; n = 32), temporoman-
dibular joint (TMJ) surgery (n = 12), den-
tal extraction (n = 113), and other minor
surgery (n = 79) (Table 1).
A PONV score was calculated for every
patient preoperatively; this score varied
between 0.1 and 0.8 and was based on
sex, history of motion sickness and
PONV, smoking status, the use of periop-
erative and postoperative opioids, type ofg after oral and maxillofacial surgery: a
.11.018
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Table 2. Patients who experienced postoper-
ative nausea (PON) according to surgical
group.
Surgical group
Nausea
No Yes Yes %
Other minor surgery 50 29 36.7
BIMAX/SARPE/Le Fort I 20 52 72.2
BSSO 8 24 75
Dental extraction 81 32 28.3
TMJ surgery 7 5 41.7
BIMAX, bimaxillary surgery; BSSO, bilateral
sagittal split osteotomy; SARPE, surgically
assisted rapid palatal expansion; TMJ, tempo-
romandibular joint.
Table 3. Patients who experienced postoper-
ative vomiting (POV) according to surgical
group.
Surgical group
Vomiting
No Yes Yes %
Other minor surgery 67 12 15.2
BIMAX/SARPE/Le Fort I 41 31 43.1
BSSO 22 10 31.2
Dental extraction 102 11 9.7
TMJ surgery 11 1 8.3
BIMAX, bimaxillary surgery; BSSO, bilateral
sagittal split osteotomy; SARPE, surgically
assisted rapid palatal expansion; TMJ, tempo-
romandibular joint.
Table 4. Differences in postoperative nausea (PON) between the indicated surgical groups.
Surgical groups Estimate P-value
Other minor surgery vs. BIMAX/SARPE/Le Fort I 1.5002 0.0003a
Other minor surgery vs. BSSO 1.6433 0.0055a
Other minor surgery vs. dental extraction 0.384 0.7421
Other minor surgery vs. TMJ surgery 0.2083 0.9976
BIMAX/SARPE/Le Fort I vs. BSSO 0.1431 0.9985
BIMAX/SARPE/Le Fort I vs. dental extraction 1.8842 0.0001a
BIMAX/SARPE/Le Fort I vs. TMJ surgery 1.292 0.2703
BSSO vs. dental extraction 2.0273 0.0002a
BSSO vs. TMJ surgery 1.4351 0.2714
Dental extraction vs. TMJ surgery 0.5922 0.8791
BIMAX, bimaxillary surgery; BSSO, bilateral sagittal split osteotomy; SARPE, surgically
assisted rapid palatal expansion; TMJ, temporomandibular joint.
a Statistically significant, P < 0.05.surgery, age, and duration of surgery11.
The specific anaesthesia protocol for each
patient was based on this PONV score.
Postoperatively, each patient remained in
the recovery unit until discharge by the
anaesthesiologist. Depending on the type
of surgery, the patients then went home or
were hospitalized.
An online questionnaire was completed
by each participant 3 days after surgery,
and the completed questionnaire was e-
mailed to the Department of Oral and
Maxillofacial Surgery, University Hospi-
tals Leuven. Each patient was assigned a
specific number in order to ensure patient
privacy. The questionnaire asked six ques-
tions: (1) Do you have a history of post-
operative nausea or vomiting? (2) Did you
have symptoms of nausea and vomiting
before surgery? (3) Did you suffer from
nausea after surgery? (4) Did you vomit
after surgery? (5) Did you ask for medi-
cine to treat nausea and vomiting postop-
eratively? (6) Did the medicine reduce the
nausea or vomiting? The patients an-
swered these questions using multiple
choice responses.
The data analysis was performed by a
certified statistician. A P-value of <0.05
was considered statistically significant.
Results
Of note, it was found that all patients
who experienced postoperative vomiting
(POV) also experienced postoperative nau-
sea (PON). Of the 308 patients, 21.1%
(n = 65) experienced POV and PON, while
another 25% (n = 77) experienced PON
alone. Thus, overall, 46.1% of the patients
experienced PON and 21.1% experienced
POV. When the data were assessed for each
surgery type separately, PON appeared to
differ between surgery types. PON was
experienced by 41.7% of patients who
underwent TMJ surgery, 28.3% who un-
derwent dental extraction, 75% who under-
went BSSO, 72.2% who underwent
BIMAX/SARPE/Le Fort I osteotomy,
and 36.7% who underwent other minor
surgeries (Table 2). Furthermore, 43.1%
of the patients who underwent BIMAX/
SARPE/Le Fort I osteotomy, 31.2% who
underwent BSSO, 9.7% who underwent
dental extraction, 8.3% who underwent
TMJ surgery, and 15.2% who underwent
other minor surgeries experienced POV
(Table 3).
The BIMAX/SARPE/Le Fort I groupand
the BSSO group had significantly higher
PON rates than the other minor surgery
group (P = 0.0003 and P = 0.0055, respec-
tively) and the dental extraction group
(P = 0.0001 and P = 0.0002, respectively).Please cite this article in press as: Dobbele
prospective study, Int J Oral Maxillofac SuThe P-values for the other between-group
comparisons can be found in Table 4.
A similar pattern was observed for the
POV group, although there was no signifi-
cant difference between the BSSO group
and the other minor surgery group. Signif-
icance was found for BIMAX/SARPE/Le
Fort I versus other minor surgery
(P = 0.0031), for BIMAX/SARPE/Le Fort
I versus dental extraction (P = 0.0001),
and for BSSO versus dental extraction
(P = 0.0348). The P-values for the other
between-group comparisons can be found
in Table 5.ir M, et al. Postoperative nausea and vomitin
rg (2018), https://doi.org/10.1016/j.ijom.2017General anaesthesia was usually in-
duced with propofol and maintained with
volatile anaesthetic gas, or induced and
maintained with target-controlled infusion
(TCI) with propofol. General anaesthesia
was maintained with desflurane for 62
patients (20.1%), sevoflurane for 161
patients (52.3%), and TCI with propofol
for 85 patients (27.6%). PON was ob-
served in 45.2% of the patients who re-
ceived desflurane, in 37.3% who received
sevoflurane, and in 63.5% who received
TCI with propofol. A significant differ-
ence in PON was seen between the sevo-
flurane group and the TCI with propofol
group (P = 0.0005); PON was significant-
ly less observed when anaesthesia was
maintained with sevoflurane than when
maintained with TCI with propofol.
When TCI with propofol was adminis-
tered, 27 patients (31.8% of the patients
who were maintained with TCI propofol)
had POV. When desflurane was used, 11
patients (17.7% of those maintained with
desflurane) had POV, and when sevoflur-
ane was used, 27 patients (16.8% of those
maintained with sevoflurane) had POV.
The relationship between the preopera-
tive PONV score and the incidence of
PONV was analyzed using a generalized
linear model for binomial data and a logit
link. PONV was considered a numerical
variable in this case. Borderline signifi-
cance was found (P = 0.0502), with a
coefficient of 1.1083 (Fig. 1).
Discussion
Silva et al. described a high incidence of
PONV after orthognathic surgery7. In the
present study, a very high incidence of
PONV after both mandibular and maxil-
lary surgery was found. Before this pro-
spective analysis was started, it was
predicted that there would be a higher
incidence of PONV after maxillary sur-
gery and a lower incidence of PONV afterg after oral and maxillofacial surgery: a
.11.018
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Table 5. Differences in postoperative vomiting (POV) between the indicated surgical groups.
Surgical groups Estimate P-value
Other minor surgery vs. BIMAX/SARPE/Le Fort I 1.4402 0.0031a
Other minor surgery vs. BSSO 0.9313 0.3352
Other minor surgery vs. dental extraction 0.5073 0.7916
Other minor surgery vs. TMJ surgery 0.6781 0.9724
BIMAX/SARPE/Le Fort I vs. BSSO 0.5089 0.7945
BIMAX/SARPE/Le Fort I vs. dental extraction 1.9475 0.0001a
BIMAX/SARPE/Le Fort I vs. TMJ surgery 2.1183 0.2872
BSSO vs. dental extraction 1.4386 0.0348a
BSSO vs. TMJ surgery 1.6094 0.6048
Dental extraction vs. TMJ surgery 0.1708 0.9999
BIMAX, bimaxillary surgery; BSSO, bilateral sagittal split osteotomy; SARPE, surgically
assisted rapid palatal expansion; TMJ, temporomandibular joint.
a Statistically significant, P < 0.05.
Fig. 1. Scatter plot of postoperative nausea and vomiting (PONV) cases versus PONV scores.
PONV cases were coded as ‘1’; non-PONV cases were coded as ‘0’. In order to show the density
of the observations, jitter was added to the figure by adding a small random value to the PONV
code values. The line on the figure shows the values as predicted by a general linear mixed
model.mandibular osteotomy. This prediction
was based on the higher perioperative
and postoperative blood loss in maxillary
surgery and on the smaller bleeding risk
in mandibular osteotomy24,25. It was not
expected that so many patients (75%)
would report PON after mandibular
osteotomy. The factors that increase the
incidence of PONV have been described
by Apfel et al.8,11, and include age, female
sex, a history of motion sickness or
PONV, non-smoking status, opioid use,
duration of surgery, and type of surgery.
In this analysis, the PONV score was a
relatively good predictor of PONV after
oral and maxillofacial surgery; however,
a higher correlation between the PONV
score and the resulting PONV was
expected. The lower correlation was
probably due to the effective anti-emetic
protocol used at the University Hospitals
Leuven, where the type of anaesthesia isPlease cite this article in press as: Dobbele
prospective study, Int J Oral Maxillofac Subased on the patient’s PONV score. If a
patient has a high preoperative PONV
score, the anaesthesiologist will mainly
adjust the maintenance protocol to use
TCI anaesthesia and avoid the use of
volatile anaesthetic gas15. Furthermore,
the attending anaesthesiologist adminis-
ters anti-emetic drugs based on the pre-
operatively calculated PONV score.
When the PONV score is 0.2, dexa-
methasone is administered. When the
PONV score is between 0.2 and 0.6,
ondansetron is added. Finally, when the
score is >0.6, the anaesthesiologist com-
bines dexamethasone and ondansetron
together with dehydrobenzperidol. How-
ever, in some cases, anaesthesia is not
performed or anti-emetics are not admin-
istered based on the PONV score; rather,
in a few patients these decisions are based
on the personal preference of the attend-
ing anaesthesiologist.ir M, et al. Postoperative nausea and vomitin
rg (2018), https://doi.org/10.1016/j.ijom.2017This study also identified differences in
PON and POV between the indicated sur-
gical groups: a significant difference in
PONV was found between the different
types of maxillofacial surgery, especially
when maxillary surgery (BIMAX/
SARPE/Le Fort I osteotomy) and BSSO
procedures were compared to the other
different types of maxillofacial surgery.
Despite the avoidance of inhalation an-
aesthesia and the use of TCI with propofol
when a patient had a high preoperative
PONV score, the incidences of nausea
(63.5%) and vomiting (31.8%) were
higher in the TCI group. This suggests
that blood loss during surgery has a major
impact on PONV. Unfortunately, pro-
jected intraoral blood loss is not yet in-
cluded in the preoperative PONV score.
Nevertheless, anaesthesiologists from
the University Hospitals Leuven mainly
use TCI with propofol during orthognathic
surgery.
In the post-anaesthesia care unit
(PACU), nurses treat PONV and pain as
quickly as possible. If the patient’s profile
warrants it, the attending anaesthesiologist
may decide to treat PONV with an extra
dose of anti-emetics. A prescription for
anti-emetic medication was given to each
patient at discharge in case of PONV at
home.
Many variables such as sex, history of
motion sickness and PONV, smoking sta-
tus, the use of perioperative and postoper-
ative opioids, age, and the duration of
surgery are already taken into account in
the PONV score. However, because oral
and maxillofacial surgery is not yet in-
cluded in the PONV score, the main goal
of the present study was to determine the
specific types of procedure in oral and
maxillofacial surgery that contribute more
to PONV. Further studies with larger num-
bers of patients will be required to deter-
mine whether sex, history of motion
sickness and PONV, smoking status, the
use of perioperative and postoperative
opioids, age, and the duration of surgery
have a specific impact on PONV in oral
and maxillofacial surgery.
This study found a high incidence of
PONV after oral and maxillofacial surgery,
especially after orthognathic surgery, de-
spite the use of an effective anti-emetic
protocol at thestudyinstitution.Mandibular
osteotomies (BSSO procedures) showed
the highest incidence of PON, while bimax-
illary surgery, SARPE, and Le Fort I osteot-
omy showed the highest incidence of POV.
Since maxillary surgery and BSSO proce-
dures induced significantly more PONV
than the other maxillofacial procedures,
these could be included as a parameter ing after oral and maxillofacial surgery: a
.11.018
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but statistically significant relationship was
detected between the preoperatively calcu-
lated PONV score and the incidence of
PONV. PONV is one of the most unpleasant
and frequent complications after surgery.
It reduces patient satisfaction and increases
hospital healthcare costs. Thus, it remains
important to develop strategies to minimize
PONV after orthognathic surgery.
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